Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Diaphragmatic Movement Before and After Stellate Ganglion Block : A Ultrasonographic Study

This study has been completed.
Sponsor:
Information provided by:
Yonsei University
ClinicalTrials.gov Identifier:
NCT01054378
First received: January 21, 2010
Last updated: December 6, 2010
Last verified: December 2010

January 21, 2010
December 6, 2010
January 2010
March 2010   (final data collection date for primary outcome measure)
The amplitude of diaphragm movement before and after SGB during quiet breathing, deep breathing and voluntary sniff, inspiratory time and expiratory time, oxygen saturation [ Time Frame: The ultrasonographic evaluation will take place just before and 30 minutes after stellate ganglion block. ] [ Designated as safety issue: No ]
The amplitude of diaphragm movement before and after SGB during quiet breathing, deep breathing and voluntary sniff, inspiratory time and expiratory time, oxygen saturaion [ Time Frame: The ultrasonographic evaluation will take place just before and 30 minutes after stellate ganglion block. ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01054378 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Diaphragmatic Movement Before and After Stellate Ganglion Block : A Ultrasonographic Study
Not Provided

The temporary diaphrgmatic dysfunction will occur after stellate ganglion block(SGB) and will be easily detected by M-mode ultrasonography

Not Provided
Interventional
Phase 4
Primary Purpose: Treatment
  • Head Pain
  • Neck Pain
  • Shoulder Pain
  • Arm Pain
  • Neural Sensory Hearing Loss
Procedure: M-mode ultrasonography
Evaluation of diaphragmatic movement using M-mode ultrasonography before and after stellate ganglion block with 1% lidocaine
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
43
April 2010
March 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • ASA class I-II patients who have head and neck pain or shoulder pain or sudden sensory neural hearing loss

Exclusion Criteria:

  • coagulopathy, pulmonary disease, neuropathy
Both
20 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT01054378
4-2009-0614
Not Provided
Duck Mi Yoon/Professor of Anesthesiology and Pain Medicine,, Yonsei University College of Medicine, Seoul, South Korea,
Yonsei University
Not Provided
Principal Investigator: Duck Mi Yoon Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea
Yonsei University
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP